Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Feb 14.
Published in final edited form as: Chem Commun (Camb). 2017 Feb 14;53(14):2226–2229. doi: 10.1039/c6cc07722f

Benzimidazopurine nucleosides from N6-aryl adenosine derivatives by PhI(OAc)2-mediated C–N bond formation, no metal needed

Sakilam Satishkumar a, Mahesh K Lakshman a,b,
PMCID: PMC5309161  NIHMSID: NIHMS837347  PMID: 27976760

Abstract

The reaction of a variety N6-aryl 2’-deoxyadenosine and adenosine derivatives with PhI(OAc)2 in 1,1,1,3,3,3-hexafluoro-2-propanol provides facile access to benzimidazopurine nucleoside analogues by metal-free C–N bond formation with a purinyl nitrogen atom. These reactions likely proceed via radical-cation/radical processes as indicated by radical inhibition experiments.


Modified nucleosides are central in disease treatment, particularly as antiviral and anticancer agents.13 Thus, approaches to the facile modification of these exceptionally important biomolecules is of paramount importance, particularly in the context of emerging viral diseases as well as resistance to existing drugs.3 Modified nucleosides are also important biological probes, such as for fluorescence monitoring.4

Hypervalent iodine reagents have gained importance as reagents because they are easy to synthesize and handle, and cross-dehydrogenative coupling products can be obtained in the absence of any metal catalyst. Hence, they find novel applications in the synthesis of heterocyclic compounds.57 Of relevance to the present work are the approaches to synthesis of benzimidazoles and azabenzimidazoles using hypervalent iodine reagents. Examples include cyclizations of appropriate precursors with PhI/CH3CO3H,8 PhI(OAc)2 or PhI(OTFA)2,911 PhI(OAc)2/m-CPBA/p-TsOH or Koser’s reagent,12 and rearrangements of N-benzyl-2-aminopyridines.13

Hypervalent iodine reagents have not seen significant use for modifying nucleosides, and this represents a new area for investigation. To our information, there is only a single report in the literature wherein 2’,3’,5’-tri-O-acetyl-protected N6-aryl adenosine derivatives were converted to benzimidazopurine nucleoside analogues via the reaction with PhI(OAc)2/Cu(OTf)2 in AcOH-Ac2O, at 80 °C.14 Not only was a metal catalyst necessary for the conversion but also the applicability of this chemistry to the substantially more sensitive purine 2’-deoxyribonucleosides is presently unknown. Pertinent to the stability discussion of nucleosides, at 37 °C, the t½ for the deglycosylation of 2’-deoxyadenosine was found to be 15 min in 0.1 M HCl.15 By contrast, the t½ for deglycosylation of adenosine was 11 days under the same conditions.15

In order to evaluate the applicability of the previously reported conditions to the 2’-deoxyribosyl series, we conducted a preliminary experiment wherein N6-phenyl-3’,5’-di-O-(t-butyldimethylsilyl)-2’-deoxyadenosine, 1 in Scheme 1, was exposed to PhI(OAc)2/Cu(OTf)2 in AcOH-Ac2O, at 80 °C. Only ca. 11% of the product was isolated. By contrast, 88% yield of the corresponding product has been reported from N6-phenyladenosine 2’,3’,5’-tri-O-acetate.14 This clearly showed that a method is needed that goes beyond the relatively stable purine ribonucleoside substrates with stability-enhancing protecting groups.

Scheme 1.

Scheme 1

Initial test of a C–N bond formation in comparison to a known result (the new bond formed is shown with a solid line).

This led us to consider other options for producing a C–N bond-forming reaction between the purinyl N1 atom and the aryl ring. A variety of solvents have been utilized in prior heterocyclic syntheses involving I(III) reagents, which include CH2Cl2, ClCH2CH2Cl (DCE), MeCN, and fluorinated solvents such as 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), and 2,2,2-trifluoroethanol (TFE). The last two solvents are notable not only for their pKa values (HFIP = 9.3, TFE = 12.9)16 but also for their ability to sustain radical cations17 that can be formed in reactions with hypervalent iodine reagents. Thus, we conducted a screening of conditions for the conversion of 12 (see Scheme 1), and the data are shown in Table 1.

Table 1.

Optimization of conditions for the reaction of substrate 1 with PhI(OAc)2a

graphic file with name nihms837347t1.jpg
Entry Additive Solvent, T °C Time Result
1b Cu(OTf)2 5 mol % AcOH, Ac2O, 80 °C 2 h 11%c
2d Cu(OTf)2 5 mol % MeCN, 80 °C 2 h 39%
3 MeCN, 55 °C 4 h 61%e
4 PhMe, 55 °C 16 h 20% (inc)f
5 ClCH2CH2Cl, 55 °C 16 h 7% (inc)
6 DMF, 55 °C 16 h 13% (inc)
7 1,4-Dioxane, 55 °C 22 h 7% (inc)
8 MeNO2, 55 °C 4 h 46%
9 TFE, 55 °C 4 h 75%
10 HFIP, 55 °C 2.5 h 78%
11 HFIP, 25–30 °C 4 h 92%
12g HFIP, 25–30 °C 4 h 64%
a

Reactions were performed at 0.1 M concentration of 1 (0.05 mmol) with 1.3 equiv. of PhI(OAc)2, except where indicated, and yields are of chromatographically isolated product.

b

As published (ref 14), 1.5 equiv. of PhI(OAc)2 was used in 1 : 1 AcOH/Ac2O (0.34 mL).

c

Clean conversion was not observed.

d

Amount of PhI(OAc)2 used was 1.5 equiv.

e

Byproducts were formed and the reaction was not clean.

f

About 29% of 1 was recovered after 16 h, inc = incomplete.

g

Amount of PhI(OAc)2 used was 1.0 equiv.

From Table 1, certain factors become evident. AcOH/Ac2O is clearly detrimental and MeCN proved to be better, more so in the absence of Cu(OTf)2. Reactions in PhMe, DCE, DMF, and 1,4-dioxane remained incomplete (inc). Finally, in MeNO2 a cleaner reaction was observed but good to excellent outcomes occurred in TFE and HFIP. In fact, a high 92% yield was observed at room temperature in a relatively fast reaction. Reducing the amount of PhI(OAc)2 from 1.3 to 1.0 equiv. lowered the product yield. Having identified optimal conditions, a series of N6-aryl 2’-deoxyadenosine and adenosine derivatives were evaluated (please see the Supporting Information for approaches to precursors). Results of the cyclization reactions are shown in Figure 1.

Figure 1.

Figure 1

Reaction times and product yields from the cyclization reactions (the new bond formed is shown with a solid line). a Yield from a 0.9 mmol reaction.

From these reactions, several facts emerge. The conditions are readily applicable to the 2’-deoxyribose precursors. A lower yield was observed in the naphthyl case 7. This reaction was conducted in MeCN because in HFIP, the substrate was decomposed. The product yield here was similar to that reported from 2’,3’,5’-tri-O-acetyl N6-(1-naphthyl)adenosine (40%).14 Thus, the 1-naphthyl moiety appears to be responsible for the two outcomes. However, in our case we also obtained a second, fairly unstable product. By carefully evaluating its spectroscopic data, we propose the iminoquinone structure 7’ (12% yield, overall yield of products was 50%), and not the peri-annulated perimidine that would result from the reaction of the purinyl N1 atom at the C8 position of the naphthalene. The rationale for the structural assignment to 7’ arises from (a) the J values of the two coupled doublets at δ = 7.05 and 6.70 ppm (≈10.5 Hz) and (b) the appearance of a 13C resonance at δ = 185.1 ppm. These data appear typical of N-aryl-1,4-naphthoquinone monoimines.18 A potential mechanism for the formation of 7’ is described under the mechanistic analysis that follows. As seen from products 5 and 8 as well as 13 and 14, there was practically no difference in the reactivities of 2’-deoxyribosyl and ribosyl precursors. Protecting groups elicit no influence as seen from the yields of products 5 and 13 as well as 8 and 14.

Notably, the yield of 14 is higher via this procedure in comparison to the literature14 (86% versus 62%). Similarly, the high 87% yield of product 12 can be contrasted to the 51% obtained from the corresponding 2’,3’,5’-tri-O-acetyl N6-(o-methylphenyl)adenosine.14 In addition to these observations, the reactions are generally insensitive to substituent effects because methoxy, halogen, acetyl, and nitrile are all well tolerated. We also evaluated reactions with the di-O-silyl N6-(p-nitrophenyl) and N6-(o-nitrophenyl) 2’-deoxyadenosine derivatives, anticipating a lack of reactivity due to the extreme electron deficiency. Consistent with this, no product formation was observed. It should be noted that the complete absence of reactivity in the presence of nitro groups has been recorded once in reactions mediated by an I(III) reagent,10 other benzimidazole syntheses generally do not report reactivity or lack thereof with this substituent. As seen in Fig. 2, the products exhibit interesting properties under UV light that appear to be modulated by the aryl ring substituents. Further studies along these lines are anticipated in future work.

Figure 2.

Figure 2

Fluorescence of the eleven compounds (1 mg mL−1 in CH2Cl2) under a 365 nm UV lamp.

Reactions mediated by PhI(OAc)2 and PhI(OTFA)2 can proceed via multiple pathways, namely, radical cations,19 nitrogen-centered radicals,20 and nitrenum ions.21 Therefore, in order to gain mechanistic insight, we chose to perform radical inhibition experiments using 2,6-di-t-butyl-4-methylphenol (BHT) and 1,1-diphenylethene (DPE), both of which have seen prior use in the evaluation of potential radical pathways in I(III)-mediated reactions.10,22 Thus, two 2’-deoxyribosides and one riboside with varying electronics in the N6-aryl ring of the adenine moiety were selected. Reactions were conducted with 1.3 equiv. of PhI(OAc)2 in HFIP at room temperature, in the presence of 1 equiv. of BHT or DPE. The results are summarized in Table 2.

Table 2.

Inhibition experiments with three substratesa

graphic file with name nihms837347t2.jpg
Entry R =
X =
Inhibitor
time
Resultb
1 H BHT Trace of product, 81% SM recovered
H 4 h
2 H DPE Trace of product, 57% SM recovered
H 4 h
3 CN BHT 88% SM recovered
OTBDMS 4 h
4 CN DPE 89% SM recovered
OTBDMS 4 h
5 OMe BHT Trace of product, 76% SM recovered
H 1 h
6 OMe DPE Trace of product, 90% SM recovered
H 1 h
a

Reactions were performed with 0.05 mmol of each substrate, 1.3 equiv. of PhI(OAc)2, and 1.0 equiv. of the inhibitor.

b

Product, when detected, was identified by thin-layer chromatography, and starting material (SM) was recovered by chromatography.

From these experiments it appears that radical species could be the reactive intermediates. As shown in Scheme 2, should the formation of radical cations (I) become feasible, as with an electron-rich aryl ring, the capture by the N1 atom could lead to species II. Alternatively, the reaction of PhI(OAc)2 at the exocyclic nitrogen atom can lead to III that can fragment via a radical pathway to IV. A reaction via the N1 atom (resonance form IV’) can also lead to II, ultimately resulting in product via the loss of a hydrogen radical. It should be noted that PhI was isolated from the two 0.9 mmol reactions reported in Figure 1.

Scheme 2.

Scheme 2

Plausible mechanistic courses for the transformation via radical intermediates.

The formation of byproduct 7’ can be rationalized on the basis of Scheme 2. Aryl amides and anilines are known to undergo oxidation with I(III) reagents,23,24 and the former undergo hydroxylation at the para position via an oxidative dearomatization.23 In a similar manner, the N6-(1-naphthyl)-2’-deoxyadenosine precursor can undergo acetoxylation via a nitrenium ion formed from III (a radical process via IV is also plausible). Hydrolysis of the resulting acetate can occur in isolation procedures, as we have previously observed.25 The resulting 4-hydroxy-1-naphthylamine derivative can then undergo rapid oxidation to iminoquinone 7’, a structure which would also account for its instability. Support for this pathway can also be obtained in the aromatic acetoxylation observed in PhI(OAc)2-mediated cyclizations of N-(biphenyl)pyridin-2-amines.10

In conclusion, we have demonstrated facile conversion of N6-aryl adenine nucleosides to benzimidazopurine nucleoside derivatives by simply utilizing PhI(OAc)2 in HFIP, at room temperature, with MeCN as a solvent of second choice. No metal catalyst is necessary for this reaction. Generally good reactions were observed and they are independent of the protecting groups used, show good functional group compatibility, and are not influenced by a substituent proximal to the reaction site. This chemistry, which is applicable to both 2’-deoxyribosides as well as ribosides, should be a significant contributor to nucleoside modification strategies, providing a rapid access to a variety of novel compounds with potentially diverse applications, from medicinal products to detection tools.

Supplementary Material

SI

Acknowledgments

Support of this work by NSF grant CHE-1265687 is gratefully acknowledged. Infrastructural support at CCNY was provided by NIH grant G12MD007603 from the National Institute on Minority Health and Health Disparities. We thank Ms. Dellamol Sebastian for assistance with the large-scale reactions, Dr. Lijia Yang for mass spectrometric data, two reviewers for insightful comments, and Mr. Satish Lakshman (Pixiedust) for assistance with the cover design.

Footnotes

Electronic Supplementary Information (ESI) available: [experimental procedures and detailed structural evaluation data]. See DOI: 10.1039/x0xx00000x

Notes and references

  • 1.(a) Herdewijn P, editor. Modified Nucleosides: In Biochemistry, Biotechnology and Medicine. Weinheim, Germany: Wiley-VCH; 2008. [Google Scholar]; (b) Vaghefi M, editor. Nucleoside Triphosphates and their Analogs: Chemistry, Biotechnology, and Biological Applications. Boca Raton, FL: CRC Press; 2005. [Google Scholar]; (c) Chu CK, editor. Antiviral Nucleosides: Chiral Synthesis and Chemotherapy. Amsterdam: Elsevier; 2003. [Google Scholar]
  • 2.(a) Jordheim LP, Durantel D, Zoulim F, Dumontet C. Nature Rev. Drug Discov. 2013;12:447–464. doi: 10.1038/nrd4010. [DOI] [PubMed] [Google Scholar]; (b) Damaraju VL, Damaraju S, Young JD, Baldwin SA, Mackey J, Sawyer MB, Cass CE. Oncogene. 2003;22:7524–7536. doi: 10.1038/sj.onc.1206952. [DOI] [PubMed] [Google Scholar]
  • 3.Torrance PF, editor. Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats. Hoboken, NJ: John Wiley & Sons, Inc.; 2005. [Google Scholar]
  • 4.(a) Matarazzo A, Hudson RHE. Tetrahedron. 2015;71:1627–1657. [Google Scholar]; (b) Su X, Xiao X, Zhang C, Zhao M. Appl. Spectrosc. 2012;66:1249–1262. doi: 10.1366/12-06803. [DOI] [PubMed] [Google Scholar]; (c) Tanpure AA, Pawar MG, Srivatsan SG. Isr. J. Chem. 2013;53:366–378. [Google Scholar]; (d) Sinkeldam RW, Greco NJ, Tor Y. Chem. Rev. 2010;110:2579–2619. doi: 10.1021/cr900301e. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Wilson JN, Kool ET. Org. Biomol. Chem. 2006;4:4265–4274. doi: 10.1039/b612284c. [DOI] [PubMed] [Google Scholar]; (f) Wiebe LI. Braz. Arch. Biol. Technol. 2007;50:445–459. [Google Scholar]; (g) Hawkins ME. In: Topics in Fluorescence Spectroscopy, Vol. 7: DNA Technology. Lakowicz JR, editor. New York: Kluwer Academic/Plenum Publishers; 2003. pp. 151–175. [Google Scholar]
  • 5.(a) Hypervalent Iodine Chemistry Wirth T, editor. Top. Curr. Chem. Vol. 373. Switzerland: Springer International Publishing; 2016. Yoshimura A, Zhdankin VV. Chem. Rev. 2016;116:3328–3435. doi: 10.1021/acs.chemrev.5b00547. Zhdankin VV. Hypervalent Iodine Chemistry: Preparation, Structure and Synthetic Applications of Polyvalent Iodine Compounds. Chichester, UK; John Wiley & Sons, Ltd.; 2014. (d) Hypervalent Iodine Chemistry: Modern Developments in Organic Synthesis Wirth T, editor. Top. Curr. Chem. Vol. 224. Berlin Heidelberg: Springer-Verlag; 2003. Varvoglis A. Hypervalent Iodine in Organic Synthesis. San Diego, CA: Academic Press; 1997.
  • 6.For selected recent reviews, please see: Narayan R, Manna S, Antonchick AP. Synlett. 2015;26:1785–1803. Singh FV, Wirth T. Chem. Asian J. 2014;9:950–971. doi: 10.1002/asia.201301582. Parra A, Reboredo S. Chem. Eur. J. 2013;19:17244–17260. doi: 10.1002/chem.201302220. Finkbeiner P, Nachtsheim BJ. Synthesis. 2013;45:979–999. Pouységu L, Deffieux D, Quideau S. Tetrahedron. 2010;66:2235–2261. Dohi T, Kita Y. Chem. Commun. 2009:2073–2085. doi: 10.1039/b821747e. Zhdankin VV. Arkivoc. 2009;(i):1–62. Zhdankin VV, Stang PJ. Chem. Rev. 2008;108:5299–5358. doi: 10.1021/cr800332c. Moriarty RM. J Org. Chem. 2005;70:2893–2903. doi: 10.1021/jo050117b. Zhdankin VV, Stang PJ. Chem. Rev. 2002;102:2523–2584. doi: 10.1021/cr010003+.
  • 7.For recent reviews see: Murarka S, Antonchick AP. Top. Curr. Chem. 2016;373:75–104. doi: 10.1007/128_2015_647. Zheng ZS, Zhang-Negrerie D, Du YF, Zhao K. Sci. China Chem. 2014;57:189–214.
  • 8.He Y, Huang J, Liang D, Liu L, Zhu Q. Chem. Commun. 2013;49:7352–7354. doi: 10.1039/c3cc43784a. [DOI] [PubMed] [Google Scholar]
  • 9.Chu J-H, Huang H-P, Hsu W-T, Chen S-T, Wu M-J. Organometallics. 2014;33:1190–1204. [Google Scholar]
  • 10.Chu J-H, Hsu W-T, Wu Y-H, Chiang M-F, Hsu N-H, Huang H-P, Wu M-J. J Org. Chem. 2014;79:11395–11408. doi: 10.1021/jo501822m. [DOI] [PubMed] [Google Scholar]
  • 11.Qian G, Liu B, Tan Q, Zhang S, Xu B. Eur. J. Org. Chem. 2014:4837–4843. [Google Scholar]
  • 12.Rao DN, Rasheed S, Vishwakarma RA, Das P. RSC Adv. 2014;4:25600–25604. [Google Scholar]
  • 13.Liang D, He Y, Liu L, Zhu Q. Org. Lett. 2013;15:3476–3479. doi: 10.1021/ol4015656. [DOI] [PubMed] [Google Scholar]
  • 14.Qu G-R, Liang L, Niu H-Y, Rao W-H, Guo H-M, Fossey JS. Org. Lett. 2012;14:4494–4497. doi: 10.1021/ol301848v. [DOI] [PubMed] [Google Scholar]
  • 15.Rios AC, Yu HT, Tor Y. J Phys. Org. Chem. 2015;28:173–180. doi: 10.1002/poc.3318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shuklov IA, Dubrovina NV, Börner A. Synthesis. 2007:2925–2943. [Google Scholar]
  • 17.(a) Eberson L, Hartshorn MP, Persson O, Radner F. Chem. Commun. 1996:2105–2112. [Google Scholar]; (b) Eberson L, Hartshorn MP, Persson O. J Chem. Soc., Perkin Trans. 1995;2:1735–1744. [Google Scholar]
  • 18. Benites J, Meléndez J, Estela C, Ríos D, Espinoza L, Brito I, Valderrama JA. Beilstein. J. Org. Chem. 2014;10:2448–2452. doi: 10.3762/bjoc.10.255. Among a series of N-aryl-1,4-naphthaquinone monoimines, a J value of ≈10 Hz was observed for the ortho-coupled spin system of the iminoquinone moiety. In addition, the 13C NMR spectra showed a resonance at ≈185 ppm.
  • 19.(a) Kita Y, Takada T, Mihara S, Whelan BA, Tohma H. J Org. Chem. 1995;60:7144–7148. [Google Scholar]; (b) Kita Y, Tohma H, Hatanaka K, Takada T, Fujita S, Mitoh S, Sakurai H, Oka S. J Am. Chem. Soc. 1994;116:3684–3691. [Google Scholar]
  • 20.(a) Togo H, Harada Y, Yokoyama M. J Org. Chem. 2000;65:926–929. [Google Scholar]; (b) Togo H, Hoshina Y, Muraki T, Nakayama H, Yokoyama M. J Org. Chem. 1998;63:5193–5200. [Google Scholar]
  • 21.(a) Samanta R, Bauer JO, Strohmann C, Antonchick AP. Org. Lett. 2012;14:5518–5521. doi: 10.1021/ol302607y. [DOI] [PubMed] [Google Scholar]; (b) Antonchick AP, Samanta R, Kulikov K, Lategahn J. Angew. Chem. Int. Ed. 2011;50:8605–8608. doi: 10.1002/anie.201102984. [DOI] [PubMed] [Google Scholar]; (c) Amano Y, Nishiyama S. Tetrahedron Lett. 2006;47:6505–6507. [Google Scholar]; (d) Wardrop DJ, Burge MS. J Org. Chem. 2005;70:10271–10284. doi: 10.1021/jo051252r. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Misu Y, Togo H. Org. Biomol. Chem. 2003;1:1342–1346. doi: 10.1039/b301330h. [DOI] [PubMed] [Google Scholar]; (f) Wardrop DJ, Zhang W, Landrie CL. Tetrahedron Lett. 2004;45:4229–4231. [Google Scholar]; (g) Wardrop DJ, Burge MS. Chem. Commun. 2004:1230–1231. doi: 10.1039/b403081h. [DOI] [PubMed] [Google Scholar]; (h) Kikugawa Y, Nagashima A, Sakamoto T, Miyazawa E, Shiiya M. J Org. Chem. 2003;68:6739–6744. doi: 10.1021/jo0347009. [DOI] [PubMed] [Google Scholar]; (i) Kita Y, Tohma H, Inagaki M, Hatanaka K, Yakura T. Tetrahedron Lett. 1991;32:4321–4324. [Google Scholar]; (j) Kikugawa Y, Kawase M. Chem. Lett. 1990;19:581–582. [Google Scholar]
  • 22.Cho SH, Yoon J, Chang S. J Am. Chem. Soc. 2011;133:5996–6005. doi: 10.1021/ja111652v. [DOI] [PubMed] [Google Scholar]
  • 23.(a) Liu H, Wang X, Gu Y. Org. Biomol. Chem. 2011;9:1614–1620. doi: 10.1039/c0ob00749h. [DOI] [PubMed] [Google Scholar]; (b) Itoh N, Sakamoto T, Miyazawa E, Kikugawa Y. J Org. Chem. 2002;67:7424–7428. doi: 10.1021/jo0260847. [DOI] [PubMed] [Google Scholar]; (c) Kokil PB, Patil SD, Ravindranathan T, Nair PM. Tetrahedron Lett. 1979;20:989–992. [Google Scholar]; (d) Barlin GB, Riggs NV. J Chem. Soc. 1954:3125–3128. [Google Scholar]
  • 24.Monir K, Ghosh M, Mishra S, Majee A, Hajra A. Eur. J. Org. Chem. 2014:1096–1102. [Google Scholar]
  • 25.Chamala RR, Parrish D, Pradhan P, Lakshman MK. J Org. Chem. 2013;78:7423–7435. doi: 10.1021/jo4008282. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SI

RESOURCES